Upcoming MBC Conferences in March
There are several conferences this month for people living with MBC. Some can be attended virtually. Conferences geared toward patients may offer time for...
Read MoreWhat Are Radiopharmaceuticals and How Are They Used in MBC?
A drug attached to a radioactive molecule is called a radiopharmaceutical, also known as a radioactive drug. The drug attached to the radioactive molecule guides...
Read MoreFDA Approves Enhertu® for Hormone Receptor-Positive, HER2-Low or HER2-Ultralow MBC
In December 2019, the US Food and Drug Administration (FDA) originally approved trastuzumab deruxtecan (Enhertu®), an antibody drug conjugate (ADC), for people...
Read MoreDissecting Trial Information on ClinicalTrials.gov
ClinicalTrials.gov is the website where clinical trials are recorded and where you can find important information about each trial. The details we provide about...
Read MoreFDA Approves Datroway®
On January 17, 2025, the FDA approved datopotamab deruxtecan-dlnk (Datroway®, Daiichi Sankyo, Inc.) for the treatment of people with hormone receptor-positive...
Read MoreSide Effects of MBC Treatments: Fatigue
MBC treatment aims to extend life but also comes with side effects that can impact quality of life. There are ways to manage the different types of side effects...
Read MoreThe Latest Triple-Positive MBC Research
MBC tumors are commonly assessed for three markers: estrogen receptor (ER), progesterone receptor (PR), and HER2. The presence or absence of these markers—and how...
Read MoreMark Your 2025 Calendars!
Conferences take place throughout the US and other countries throughout the year that are relevant to women and men with MBC. Many of these conferences are...
Read MoreSan Antonio Breast Cancer Symposium 2024
The 2024 San Antonio Breast Cancer Symposium (SABCS) meeting was held December 10-13, 2024 in San Antonio, TX and virtually. Click the links below to read about...
Read MoreSEARCH OUR SITE
for past articles or specific information.